XML 20 R7.htm IDEA: XBRL DOCUMENT v3.22.0.1
CONSOLIDATED STATEMENTS OF CHANGES IN TOTAL EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Impact of new accounting pronouncements
Common Shares
Capital in Excess of Stated Value
Accumulated Other Comprehensive Loss
Accumulated Other Comprehensive Loss
Impact of new accounting pronouncements
Retained Earnings
Retained Earnings
Impact of new accounting pronouncements
Non- controlling Interests
Beginning Balance at Dec. 31, 2018 $ 1,772,278 $ (6,771) $ 7,175 $ 304,709 $ (740,913) $ 2,188,115 $ (6,771) $ 13,192
Beginning Balance (in shares) at Dec. 31, 2018     99,829            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income (loss) 292,668           291,785   883
Other comprehensive income/(loss):                  
Translation gain/(loss) 8,270       9,108       (838)
Defined benefit plan adjustment [1] (87,033)       (87,033)        
Derivative financial instruments [1] 2,035       2,035        
Other comprehensive income/(loss) (76,728)       (75,890)       (838)
Dividends paid to noncontrolling interests (214)               (214)
Dividends (171,597)           (171,597)    
Issuance of stock awards 1,343     1,343          
Issuance of stock awards (in shares)     538            
Shares repurchased (9,608)     (9,608)          
Shares repurchased (in shares)     (169)            
Stock-based compensation 14,334     14,334          
Ending Balance at Dec. 31, 2019 1,815,705 $ (209) $ 7,175 310,778 (816,803)   2,301,532 $ (209) 13,023
Ending Balance (in shares) at Dec. 31, 2019     100,198            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income (loss) 207,241           207,463   (222)
Other comprehensive income/(loss):                  
Translation gain/(loss) 46,092       47,970       (1,878)
Defined benefit plan adjustment [1] 11,666       11,666        
Derivative financial instruments [1] 325       325        
Other comprehensive income/(loss) 58,083       59,961       (1,878)
Dividends (173,570)           (173,570)    
Issuance of stock awards 1,154     1,154          
Issuance of stock awards (in shares)     398            
Shares repurchased (8,483)     (8,483)          
Shares repurchased (in shares)     (149)            
Stock-based compensation 10,607     10,607          
Ending Balance at Dec. 31, 2020 $ 1,910,528   $ 7,175 314,056 (756,842)   2,335,216   10,923
Ending Balance (in shares) at Dec. 31, 2020 100,447   100,447            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income (loss) $ (82,711)           (85,477)   2,766
Other comprehensive income/(loss):                  
Translation gain/(loss) (75,636)       (75,052)       (584)
Defined benefit plan adjustment [1] 471,350       471,350        
Derivative financial instruments [1] 1,119       1,119        
Other comprehensive income/(loss) 396,833       397,417       (584)
Dividends paid to noncontrolling interests (1,009)               (1,009)
Dividends (179,734)           (179,734)    
Issuance of stock awards 1,111     1,111          
Issuance of stock awards (in shares)     309            
Shares repurchased (218,085)     (218,085)          
Shares repurchased (in shares)     (3,386)            
Stock-based compensation 22,608     22,608          
Ending Balance at Dec. 31, 2021 $ 1,849,541   $ 7,175 $ 119,690 $ (359,425)   $ 2,070,005   $ 12,096
Ending Balance (in shares) at Dec. 31, 2021 97,370   97,370            
[1] net of tax